- Home
- Biopharmaceutical Industry
- All premium reports
- Recombinant Protein Analysis & Statistics, May 2013
Industries
- Biopharmaceutical (30)
- Drug and Medication (8)
- Therapy (8)
- Biotechnology (6)
- Medical Equipment and Supply (6)
-
- Pharmaceutical (6)
- Drug Delivery Technology (4)
- In Vitro Diagnostic (4)
- Juice (4)
- Genomics (3)
- Biological Therapy (2)
- Genetically Modified Organism, Gmo (2)
- Healthcare (2)
- Pathology (2)
- Beer (1)
- Blood Supply, Tissue Banking and Transplantation (1)
- Drug Discovery and Development (1)
- Generic Drug (1)
- It Hosting (1)
- Soda (1)
Top countries
Publication dates
Publishers
- Global Data (60)
- Greystone Research Associates (5)
- BCC Research (4)
- MarketsandMarkets (3)
- Datamonitor (2)
-
- Global Markets Direct (2)
- International Market Analysis Research and Consult (2)
- La Merie Publishing (2)
- Research In China (2)
- Espicom Business Intelligence (1)
- GBI Research (1)
- Global Industry Analyst (1)
- Kalorama Information (1)
- SCRIP Insights (1)
- VacZine Analytics Group Of Assay Advantage Ltd (1)
All regions
data types
» Purchase Premium Reports
1-10 of 88 reports for Recombinant Protein
Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
- $ 3 500
- Industry report
- September 2010
- by GBI Research
... Increasing demand for monoclonal antibodies and recombinant proteins drives increases in capacities and innovative production technologiessummarygbi research's report, Manufacturing ...
- Industries : Biopharmaceutical, Biotechnology
- Countries : Japan, United States, India, Singapore, China, World, Europe, Asia
Global Biopharmaceutical Market Report (2010-2015)
- $ 1 000
- Industry report
- October 2010
- by International Market Analysis Research and Consult
... recombinant proteins represented the biggest biopharmaceutical class in 2009, accounting for more than 65% of the total global biopharmaceutical sales. Growth in this class is expected to be low in most ...
- Industries : Biopharmaceutical
- Countries : World
Vybion, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- March 2013
- by Global Data
... And eliminate cocaine dependency. The company provides recombinant proteins for therapeutic and diagnostic applications. It provides treatment for therapeutic areas including diabetes, inflammatory disease ...
- Industries : Biopharmaceutical
- Countries : United States
Global and China Biopharmaceutical Industry Report, 2010
- $ 1 900
- Industry report
- September 2010
- by Research In China
... And chengdu huasun group. recombinant protein drugs are widely used in the treatment of a variety of major diseases, with huge market potentials. Genescience pharmaceuticals co., Ltd. (Gensci) which ...
- Industries : Biopharmaceutical
- Countries : China
China Genetic Engineering Drug Industry Report, 2011-2012
- $ 1 900
- Industry report
- July 2012
- by Research In China
... Human insulin, 2008-2011research schedule of amoytop biotech's long-acting recombinant protein drugs, as of 2011 ...
- Industries : Biopharmaceutical
- Countries : China
Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 - 2017)
- $ 4 650
- Industry report
- December 2012
- by MarketsandMarkets
... Market (2012 - 2017) transfection is an enabler technology used for many cell based research activities with applications spanning production of recombinant proteins and recombinant cell lines, gene ...
- Industries : Genetically Modified Organism, Gmo
- Countries : World
Product Strategies for Non-Oral Hematology Drugs
- $ 2 850
- Industry report
- June 2012
- by Greystone Research Associates
... And recombinant proteins designed to treat chronic conditions that are life threatening and often debilitating illnesses. As the availability of drugs based on new apis or molecular entities has grown, the product ...
- Industries : In Vitro Diagnostic
Global Biopharmaceutical Market Report & Forecast (2012-2017)
- $ 1 200
- Industry report
- September 2012
- by International Market Analysis Research and Consult
... Forecast (2012-2017)5.3 Market segmentation by indication5.4 Market segmentation by class5.4.1 recombinant proteins5.4.1.1 Current performance (2005-2011)5.4.1.2 Market forecast (2012 ...
- Industries : Biopharmaceutical
- Countries : World
MarketVIEW: Respiratory Syncytial virus vaccines
- $ 9 995
- Industry report
- May 2012
- by VacZine Analytics Group Of Assay Advantage Ltd
... Of approaches are being pursued including live-attenuated viruses and/or recombinant proteins, the most advanced of which is astrazeneca/medimmune's medi-534 and medi-559. Us biotech novavax have also completed ...
- Industries : Drug and Medication
Advanced Devices for Injectable Drugs
- $ 2 850
- Industry report
- January 2013
- by Greystone Research Associates
... Injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices ...
- Industries : Drug Delivery Technology
» Download Public Reports
About 1 900 reports for Recombinant Protein
Recombinant Protein Industry (recombinant protein, protein)
- Industry report
- January 2012
- 19 pages
Protein Market Brief (protein, Recombinant Protein)
November 2011Protein Market (protein, Recombinant Protein) In Uruguay
February 2011Reportlinker.com © Copyright 2013. All rights reserved.
